Trials / Completed
CompletedNCT06147908
Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R
A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of DW5221 and DW5221-R in Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A bioequivalence study to compare and evaluate the pharmacokinetic characteristics and the safety after administration of DW5221 and DW5221-R in healthy adult m ale volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW5221 | megestrol acetate |
| DRUG | DW5221-R | megestrol acetate |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2022-10-26
- Completion
- 2022-11-17
- First posted
- 2023-11-28
- Last updated
- 2023-11-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06147908. Inclusion in this directory is not an endorsement.